Florin‐Andrei Taran

机构：University of Cologne, University Medical Center Freiburg, Düsseldorf University Hospital, Integrated Oncology (United States), University Hospital Cologne, Heinrich Heine University Düsseldorf · ORCID：0000-0001-9167-047X

发表论文 185 篇 · 总被引 34794 次 · h-index 32

代表论文

• Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT (2022 · Geburtshilfe und Frauenheilkunde · 被引 30)
• Comparison of therapy benefit from standard anti-HER2 directed approaches in metastatic breast cancer (MBC) between initially HER2-positive patients and patients initially HER2-negative with switch to HER2-positive. (2021 · Journal of Clinical Oncology · 被引 15)
• Lymph Node Staging with a Combined Protocol of 18F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical Carcinoma (2021 · Journal of Nuclear Medicine · 被引 14)
• Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry (2022 · European Journal of Cancer · 被引 13)
• CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs (2024 · Geburtshilfe und Frauenheilkunde · 被引 8)
• Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer (2025 · The Breast · 被引 7)